Personal information

Vaccines, Immunisation, Immunology, Intensive Care Medicine
Brazil

Activities

Employment (4)

Takeda International: Zuerich, CH

2012 to 2015 | SVP & Global Head Vaccine Development (Vaccine Development)
Employment
Source: Self-asserted source
Ralf Clemens

Novartis Pharma AG: Siena, IT

2006 to 2012 | Global Head VP Vaccine Development (Vaccine Development)
Employment
Source: Self-asserted source
Ralf Clemens

GlaxoSmithKline Latin America: Rio de Janeiro, BR

2001 to 2006 | VP & Head business strategy (Business strategy)
Employment
Source: Self-asserted source
Ralf Clemens

GlaxoSmithKline Biologicals SA: Rixensart, BE

1990 to 2000 | VP & Head Global Clinical R&D (Development)
Employment
Source: Self-asserted source
Ralf Clemens

Education and qualifications (1)

Johannes Gutenberg Universitat Mainz: Mainz, Rheinland-Pfalz, DE

1978 to 2006 | MD PhD (Anaesthesiology)
Education
Source: Self-asserted source
Ralf Clemens

Professional activities (6)

ILiAD Biotechnology: Weston, Florida, US

2024-05-01 to present | Member of Scientific Advisory Board
Service
Source: Self-asserted source
Ralf Clemens

Jenner Institute: Oxford, Oxford, GB

2023-06-01 to present | Chair Scientific Advisory Board
Service
Source: Self-asserted source
Ralf Clemens

Clover Biopharmaceuticals (China): Chengdu, CN

2022-06-17 to present | Board Member
Invited position
Source: Self-asserted source
Ralf Clemens

Inventprise (United States): Redmond, Washington, US

2022-06-01 to present | Board Member
Invited position
Source: Self-asserted source
Ralf Clemens

International Vaccine Institute: Seoul, KR

2018 to 2024 | Member Board of Trustees
Invited position
Source: Self-asserted source
Ralf Clemens

GLobal Health Innovation Fund: Tokyo, JP

2015 to 2024 | Member Selection Committee
Service
Source: Self-asserted source
Ralf Clemens

Peer review (13 reviews for 7 publications/grants)

Review activity for EClinicalMedicine. (2)
Review activity for npj vaccines. (1)
Review activity for Open forum infectious diseases. (2)
Review activity for PLOS global public health. (2)
Review activity for The Lancet regional health. (3)
Review activity for The lancet. (2)
Review activity for Vaccine. (1)